Medical Malpractice in RAK ICC: Complete Guide

Investors who hold a clinic, a diagnostic centre or a medical group through a RAK ICC company usually ask the same question when a patient complaint appears: does this reach me? The answer depends on a distinction that gets blurred in practice — the difference between a company that is registered and a facility that is licensed to treat patients.

The Ras Al Khaimah International Corporate Centre is a company registry. It incorporates and maintains companies, keeps their registers, and applies its own registry rules. It does not license health facilities, it does not license doctors, and it does not investigate clinical complaints. This guide explains where medical liability actually sits when a RAK ICC entity is in the ownership chain, and what the holding company can and cannot do about it.

Where the licence sits, and why it matters

Every clinical act in the UAE happens under a facility licence and a professional licence issued by a health regulator — the Ministry of Health and Prevention, an emirate-level authority such as the Dubai Health Authority or the Department of Health in Abu Dhabi, or the regulator of a healthcare free zone. A patient complaint goes to whichever of those bodies licensed the facility. It is that regulator that requests the medical record, refers questions of clinical judgment to specialist reviewers, and can suspend a licence.

A RAK ICC company sitting above the operating entity is a shareholder. It is not the treating facility and it is not the employer of the practitioner, so the regulatory process runs against the licensed entity below it. That separation is real, but it is not automatic protection. It survives only if the group is run as though the companies are genuinely separate.

What actually pierces the separation

• The holding company giving guarantees, indemnities or comfort letters to landlords, lenders, insurers or patients.
• Directors of the holding company involving themselves in clinical or staffing decisions at the facility.
• Marketing that presents the group as a single treating organisation, so a patient contracts with something other than the licensed entity.
• Intercompany arrangements that are undocumented, so money and staff move without any contractual basis.
• A single insurance policy assumed to cover every entity in the chain, when the named insured is one company.

How the underlying complaint is handled

Even at holding level, it is worth understanding what the operating entity is going through. The regulator takes the complaint, asks the facility for the complete record and for the practitioner's written response, and refers genuine questions of clinical judgment to specialist doctors. They ask whether the care fell below the standard expected of a reasonably competent practitioner in that specialty, and whether any departure caused the harm. A poor outcome after appropriate care is not malpractice.

Compensation is a separate matter, pursued by civil claim before the courts, where the expert opinion from the regulatory process weighs heavily. Serious allegations can also reach the police and the public prosecution. The consequence for an owner is that a single complaint can run in three places at once, on a timetable nobody in the group controls.

Owning a clinic through a holding structure

Diligence before you buy

Medical liability is the risk most often underestimated in a clinic acquisition, because the exposure is invisible on the balance sheet. Ask for the complete complaint history with the regulator, not just the ones that were settled; the licence file including any conditions, warnings or suspensions; the professional licences and their expiry position; the indemnity policies with their limits, retroactive dates and claims history; and the record retention practice, since missing records are what turns a defensible case into a lost one.

The sale documents

Warranties on regulatory compliance, licence validity and the absence of unnotified complaints do the work here, backed by an indemnity for claims arising from treatment given before completion. Since the harm may surface long after the deal, the survival period for that indemnity and the mechanism for funding it — escrow, retention or insurer-backed — matter more than the headline price adjustment.

Governance after completion

Keep the licensed entity's board decisions at the licensed entity. Document management services, staff secondments and equipment leases between group companies on proper terms. Make sure the entity that treats the patient is the entity named in the patient contract, the consent forms and the insurance policy. These are unglamorous points, and they are what a court looks at when a claimant tries to reach the shareholder.

Contracts, forum and data

Disputes inside the group and with suppliers are governed by whatever the contracts say. Where arbitration is chosen, the federal arbitration law, Federal Law No. 6 of 2018 as amended in 2023, governs UAE-seated proceedings; DIAC administers cases that previously went to the DIFC-LCIA, which was abolished by Dubai Decree No. 34 of 2021, and the DIFC remains available as a seat. The Dubai International Financial Centre and Abu Dhabi Global Market are common-law jurisdictions with their own courts, which is why the governing law and forum clauses in shareholder and management agreements repay careful drafting.

Patient data does not move freely between group companies simply because they share an owner. Processing outside DIFC and ADGM is governed by the federal data protection law, Federal Decree-Law No. 45 of 2021, and those two jurisdictions have their own regimes. Health-specific rules on medical records and disclosure, administered by the health regulator, sit on top. A holding company that pulls patient-level reporting out of a clinic needs a lawful basis for it, not just access to the system.

Tax and filings the structure does not remove

An offshore registration is not a tax status. Corporate tax under Federal Decree-Law No. 47 of 2022 applies for financial years starting on or after 1 June 2023, at 0% on taxable income up to AED 375,000 and 9% above that, and the operating clinic is squarely within it. VAT is charged at 5% under Federal Decree-Law No. 8 of 2017 as amended by Federal Decree-Law No. 18 of 2022, with healthcare supplies treated according to the rules in that legislation. On economic substance, the regulations were cancelled for financial years ending after 31 December 2022 by Cabinet Decision No. 98 of 2024, but obligations remain for the financial years from 2019 to 2022 — a dormant holding company can still have a historic filing problem.

How we help

We advise owners on both levels of this structure: the group documents, warranties, indemnities and insurance that decide whether a clinical claim stops at the operating entity, and the defence of the claim itself. Our medical dispute resolution team appears for facilities and practitioners before health authorities, expert panels, the civil courts and the prosecution, and works with shareholders on the exposure that flows upward from them.

Conclusion

A RAK ICC company changes who owns the clinic. It does not change who is licensed, who is investigated, or who answers to the patient. The protection an owner gets from the structure is only as good as the separation maintained in practice, the diligence done before buying, and the indemnity and insurance arrangements agreed at the outset.

To review a group structure, a clinic acquisition or a live complaint, contact the Nour Attorneys team.

Schedule Your Consultation

Disclaimer: The information provided in this article is for general informational purposes only and does not constitute legal advice. Readers should seek professional legal advice tailored to their specific circumstances before making any decisions or taking any action based on the content of this article.

Nour Attorneys Team

Related Resources

Explore more of our insights on related topics:

• Healthcare Facility Licensing Requirements in the UAE
• Medical Malpractice Defence Strategies for Dubai Clinics
• Pharmaceutical Compliance Guidelines for UAE Distributors
• Patient Privacy Regulations for Multinational Entities